A new agreement reached by the Global Fund and several producers of COVID-19 antigen rapid diagnostic tests (Ag RDTs) has resulted in a significant drop in the price of these tests, potentially making the products more affordable for many governments...
A new snapshot reveals the persistent and glaring inequity in access to lifesaving COVID-19 tools, such as diagnostic tests, treatments (including medical oxygen), and personal protective equipment (PPE), that is hindering the pandemic response in lo...
The new Briefing Note on Testing for both Tuberculosis and SARS-CoV-2 is now available, also in French and Spanish. It provides information for TB programs including testing for both diseases.
Principal Recipients are requested to accelerate the procurement of approved health products under C19RM awards through both Pooled Procurement Mechanism (PPM) and non-PPM channels to ensure rapid availability in their countries.
Testing is the first line of defense in the fight against COVID-19. Without testing, countries cannot track or contain the spread of the virus, address urgent clinical needs, test the efficacy of vaccines, or detect the emergence of new variants.